tirzepatide odt Microdose 1 and GIP mechanism in a daily Tirzepatide Oral: A Needle-Free Breakthrough

For Orforglipron, expect a similar but stronger tugofwar

According to the International Diabetes Federation, 537 million adults were living with diabetes in 2025 and by 2045, the number is projected to increase to 783 million, and the World Health Organization estimates that global obesity prevalence has almost tripled since 1975, and that more than 1.1 billion adults are now considered obese globally

With multiple doses, this holds the potential as a treatment option

Thymosin beta-4 has shown particular promise in cardiac muscle repair, an area where BPC-157 has less data

[4] Launch date: July 1, 2026 Medicare copay: $50/month for beneficiaries Eligibility: BMI 35, or BMI 27 with weight-related comorbidities Note: KwikPen only (vials not covered)